Patent Application
20090248317
This application claims priority under 35 U.S.C. §119 to Japanese Patent Application No. JP2008-088828 filed Mar. 28, 2008, the entire content of which is hereby incorporated by reference.
The present invention relates to a biological sample analyzer and computer program product for analyzing biological samples such as blood, urine and the like from a human patient.
Conventional sample analyzers for analyzing biological sample such as blood and urine are disclosed, for example, in U.S. Pat. No. 6,391,263 and Japanese Laid-Open Patent Publication No. 2003-083960.
A sample analyzer which allows the analysis condition to be modified according to animal species is disclosed in U.S. Pat. No. 6,391,263.
A blood analyzer which measures blood after diluting the blood with a reagent to increase the amount, and thereafter performs a calculation process to correct for the additional amount, when it is difficult to collect a sufficient amount of blood as in the case of a child, and when analyzing a sample which has an abnormally number of blood cells, is disclosed in Japanese Laid-Open Patent Publication No. 2003-083960.
Since sample attributes vary widely depending on the animal species when samples are collected from animals other than humans, analyzers have been developed which execute sample analysis after changing the analysis condition according the animal species as in the previously mentioned case of U.S. Pat. No. 6,391,263.
Because sample attributes do not vary much according to the patient when samples are collected from humans, there is no need to change the analysis condition depending on the sample. However, ever greater analysis precision has come to be required by analyzers over the years, and conventional analyzers may not meet such requirements.
For example, the blood analyzer disclosed in Japanese Laid-Open Patent Publication No. 2003-083960 performs measurements of blood which may be of insufficient quantity such as blood collected from a child under conditions which correspond to the attributes of adult human blood after having increased the quantity of the blood by diluting the blood more than usual, and cannot perform such measurements under condition which correspond to the attributes of child humans. Therefore, it is difficult to perform precision analysis in accordance with a full range of human attributes using the blood analyzer disclosed in Japanese Laid-Open Patent Publication No. 2003-083960.
A first aspect of the present invention is a biological sample analyzer, comprising: a characteristic information obtainer for obtaining characteristic information representing a characteristic of a component contained in a biological sample of a patient; a processor; and a memory storing software instructions adapted to enable the processor to perform operations comprising: (a) analyzing the characteristic information based on a first condition for analyzing a biological sample of a patient who does not have a predetermined attribution; and (b) analyzing the characteristic information based on a second condition for analyzing a biological sample of a patient who has the predetermined attribution.
A second aspect of the present invention is a biological sample analyzer, comprising: a characteristic information obtainer which obtains characteristic information representing a characteristic of a component contained in a biological sample of a patient based on a first obtaining condition when the patient does not have a predetermined attribution, and obtains characteristic information representing the characteristic of the component contained in the biological sample of the patient based on a second obtaining condition when the patient has the predetermined attribution; and a processing section for executing an operation to analyze the characteristic information obtained by the characteristic information obtainer.
A third aspect of the present invention is a computer program product for enabling a computer to control a biological sample analyzer, comprising: a computer readable medium, and software instructions, on the computer readable medium, for enabling the computer to perform predetermined operations comprising: (a) controlling the biological sample analyzer so as to obtain characteristic information representing a characteristic of a component contained in a biological sample of a patient; (b) analyzing the characteristic information based on a first condition for analyzing a biological sample of a patient who does not have a predetermined attribution; and (c) analyzing the characteristic information based on a second condition for analyzing a biological sample of a patient who has the predetermined attribution.
A fourth aspect of the present invention is a computer program product for enabling a computer to control a biological sample analyzer, comprising: a computer readable medium, and software instructions, on the computer readable medium, for enabling the computer to perform predetermined operations comprising: (a) controlling the biological sample analyzer so as to obtain characteristic information representing a characteristic of a component contained in a biological sample of a patient based on a first obtaining condition corresponding to a patient who does not have a predetermined attribution; (b) controlling the biological sample analyzer so as to obtain characteristic information representing the characteristic of the component contained in the biological sample of the patient based on a second obtaining condition corresponding to a patient who has the predetermined attribution; and (c) analyzing the characteristic information obtained in at least one of the operation (a) and the operation (b).
A blood analyzer for analyzing blood is specifically described hereinafter as an example of the biological sample analyzer of the present embodiment based on the drawings. The analysis process thus is a blood cell classification process, and the analysis data are generated as classification data. Note that the blood analyzer of the present embodiment is configured to analyze blood of human beings.
The measuring device 1 and the operation and display device 2 are connected via a communication line which is not shown in the drawing. The operation and display device 2 controls the operation of the measuring device 1, processes the measurement data output from the measuring device 1, and obtains analysis results through data communication with the measuring device 1. The measuring device 1 and the operation and display device 2 may also be connected over a network, or may be configured as a single integrated device so as to send and receive data by interprocess communication and the like.
The measuring device 1 detects characteristics information of the leukocytes, reticulocytes, and platelets in the blood using flow cytometry, and transmits the detection data as measurement data to the operation and display device 2. Flow cytometry is a measurement method which forms a sample flow that includes a measurement sample, detects light such as forward scattered light, side scattered light, and side fluorescent light that is emitted by the particles (blood cells) in the measurement sample when the measurement sample is irradiated by laser light to detect the particles (blood cells) in the measurement sample.
The control board 9 is provided with a controller 91 which has a control processor and a memory for the operation of the control processor, twelve-bit A/D converter 92 for converting the signals output from the analog processing section 6 to digital signals. And an operation section 93 for storing the digital signals output from the A/D converter 92 and executing a process for selecting data to be output top the controller 91. The controller 91 is connected to the display and operation section 7 through a bus 94a and an interface 95b, connected to the device mechanism 4 through the bus 94a and an interface 95a, and connected to the operation and display device 2 through a bus 94b and an interface 95c. The operation section 93 outputs the operation results to the controller 91 through an interface 95d and the bus 94a. The controller 91 also transmits the operation results (measurement data) to the operation and display device 2.
The device mechanism 4 is provided with a sample preparing section 41 for preparing a measurement sample from blood and reagent. The sample preparing section 41 prepares leukocyte measurement samples, reticulocyte measurement samples, and platelet measurement samples.
The sampling valve 41b is configured to be capable of determining the amount of blood within the collection tube 41a aspirated by an aspirating pipette which is not shown in the drawing. The reaction chamber 41c is connected to the sampling valve 41b, and is configured to be capable of mixing a predetermined reagent and staining solution with the fixed amount of blood determined by the sampling valve 41b. The reaction chamber 41c is also connected to the detecting section 5, and is configured so that a measurement sample prepared by mixing the predetermined reagent and staining solution in the reaction chamber 41c inflows to the detecting section 5.
The sample preparing section 41 can thus prepare a measurement sample in which the leukocytes are stained and the erythrocytes are hemolyzed as the leukocyte measurement sample. The sample preparing section 41 can also prepare a measurement sample in which the reticulocytes are stained as a reticulocyte measurement sample, and prepare a measurement sample in which the platelets are stained as a platelet measurement sample. The prepared measurement sample is supplied together with a sheath fluid to a sheath flow cell of the detecting section 5 which will be described later.
The light-emitting part 501 is provided to irradiate light on a sample flow which contains a measurement sample passing through the interior of the sheath flow cell 503. The irradiating lens unit 502 is provided to render the light emitted from the light-emitting part 501 into parallel rays. The PD 506 is provided to receive the forward scattered light emitted from the sheath flow cell 503 Note that information relating to the size of the particles (blood cells) in the measurement sample can be obtained from the forward scattered light emitted from the sheath flow cell 503.
The dichroic mirror 508 is provided to separate the side scattered light and the side fluorescent light emitted from the sheath flow cell 503. Specifically, the dichroic mirror 508 is provided to direct the side scattered light emitted from the sheath flow cell 503 to the PD 512, and to direct the side fluorescent light emitted from the sheath flow cell 503 to the APD 511. The PD 512 is also provided to receive the side scattered light. Internal information relating to the size and the like of the nucleus of the particles (blood cells) within the measurement sample can be obtained from the side scattered light emitted from the sheath flow cell 503.
The APD 511 is also provided to receive the side fluorescent light. When light irradiates a fluorescent substance such as a stained blood cell, light is emitted which has a longer wavelength that that of the irradiating light. The intensity of the fluorescence increases as the degree of staining increases. Therefore, characteristic information related to the degree of staining of the blood cell can be obtained by measuring the intensity of the side fluorescent light emitted from the sheath flow cell 503. It is therefore possible to perform other measurements in addition to classifying leukocytes by the difference in the side fluorescent light intensity. PD 506, PD 512, and APD 511 convert the optical signals of the respectively received light to electrical signals, and the converted electrical signals are then amplified by amplifiers 61, 62, and 63 and the amplified signals are transmitted to the control board 9.
In the first embodiment, the light-emitting part 501 emits light with an output of 3.4 mW during the leukocyte classification measurement (hereinafter referred to as “DIFF measurement”). The light-emitting part 501 also emits light with an output of 6 mW during the reticulocyte measurement (hereinafter referred to as “RET measurement”). The light-emitting part also emits light at an output of 10 mW during platelet measurement (hereinafter referred to as “PLT measurement”).
The memory device 23 is configured by an internal fixed type memory device (hard disk) or the like. The memory device 23 is also provided with a patient information memory device 232 which stores information relating to patients and including the age information of the patient (subject) associated with identification information which can be obtained by reading a barcode label.
The communication interface 27 is connected to the internal bus 28, and is capable of sending and receiving data when connected to the measuring device 1 through a communication line. That is, the communication interface 27 sends information instructing the start of a measurement and the like to the measuring device 1, and receives measurement data.
The input device 24 is a data input medium such as a keyboard and mouse or the like. The display device 25 is a display device such as a CRT monitor, LCD or the like, and graphically displays the analysis results. The output device 26 is a printing device such as a laser printer, inkjet printer or the like.
In the measuring device 1 and operation and display device 2 of the biological sample analyzer having the structure described above, a scattergram such as that shown in
In the biological sample analyzer of the first embodiment, a lymphocyte distribution region 101 in which lymphocytes are assumed to be distributed, a monocyte distribution region 102 in which monocytes are assumed to be distributed, an eosinphil distribution region 103 in which eosinophils are assumed to be distributed, a neutrophil distribution region 104 in which neutrophils are assumed to be distributed, and a basophil distribution region in which basophils are assumed to be distributed are predetermined based on previous statistical values of adult blood, as shown in
The present inventors acknowledge that the blood cells contained in child blood have lower stainability than blood cell contained in adult blood. It is therefore clear that the sampling values will be distributed somewhat lower in each region of the original distributions shown in
As shown in
When the distribution trend from the scattergram is entirely shifted below the assumed region as described above, the measurement data can be determined to be data from child blood, and it can be understood that the region 111 in which the sampling values cluster must be shifted in the direction of the arrow 112 to improve the accuracy of the classification process. A means is disclosed below for shifting the measurement data of child blood in order to realize a classification process which has better accuracy using the same blood cell classification method as when classifying leukocytes based on adult blood, even when the measurement data are data from child blood.
The CPU 21 of the operation and display device 2 determines whether or not a measurement start instruction has been received (step S903); when the determination of the CPU 21 is that a measurement start instruction has not been received (step S903: NO), the CPU 21 skips the subsequent steps S904 through S909. When the CPU 21 has determined that a measurement start instruction has been received (step S903: YES), the CPU 21 transmits instruction information specifying to start a measurement to the measuring device 1 (step S904). The controller 91 of the measuring device 1 determines whether or not instruction information specifying to start a measurement has been received (step S915); when the controller 91 has determined that a instruction information specifying to start a measurement has been received (step S915: YES), the controller 91 has the barcode reader (not shown in the drawing) read the barcode label (not shown in the drawing) adhered to the container which contains the blood to obtain the blood identification information (sample ID) (step S916). When the controller 91 has determined that instruction information specifying to start a measurement has not been received (step S915: NO), the controller 91 skips steps 916 through S920.
The controller 91 transmits the obtained identification information (sample ID) to the operation and display device 2 (step S917), and the CPU 21 of the operation and display device 2 determines whether or not the identification information (sample ID) has been received (step S905). When the CPU 21 determines that the identification information (sample ID) has not been received (step S905: NO), the CPU 21 enters a reception standby state. When the CPU 21 determines that the identification information (sample ID) has been received (step S905: YES), the CPU 21 obtains the patient information by querying the patient information memory device 232 of the memory device 23 (step S906), and transmits the patient information to the measuring device 1 (step S907).
The controller 91 of the measuring device 1 then determines whether or not the patient information has been received (step S918); when the controller 91 determines that the patient information has not been received (step S918: NO), the controller 91 enters a reception standby state. When the controller determines that the patient information has been received (step S918: YES), the controller 91 controls the sample preparing section 41 so as to prepare a measurement sample, and thereafter starts the measurement of a measurement sample (step S919). Specifically, the DIFF measurement is executed, and the electrical signals corresponding to the intensity of the received side scattered light and side fluorescent light are transmitted to the control board 9 via the detecting section 5 and the analog processing section 6. The A/D converter 92 of the control board 9 converts the obtained analog signals to 12-bit digital signals, and the operation section 93 subjects the digital signals output from the A/D converter 92 to predetermined processing, and transmits the signals to the controller 91. The controller 91 transmits the received 12-bit integer sequence information as measurement data to the operation and display device 2 (step S920).
The CPU 21 of the operation and display device 2 determines whether or not the measurement data have been received (step S908); when the CPU 21 determines that the measurement data have been received (step S908: YES), the CPU 21 executes an analysis process based on the received measurement data (step S909). When the CPU 21 determines that the measurement data have not been received (step S908: NO), the CPU 21 enters a reception standby state.
Specifically, the CPU 21 compresses the 12-bit integer sequence information obtained from the measuring device 1 directly to 8-bit integer sequence data when generating the first classification data, and after multiplying the 12-bit integer sequence information 1.2 times, then compresses the integer part to 8-bit integer sequence data when generating the second classification data. By multiplying the 12-bit integer sequence information 1.2 times and thereafter compressing the 8-bit data to generate the second classification data for child blood in this way, a proportion which maintains the continuity of the integer sequence values can be increased compared to when the first classification data of adult blood is simply multiplied 1.2 times to generate the second classification data.
In the first embodiment, the measurement data is obtained as integer sequence information which has a larger number of bits (12-bits) than the number of bits (8-bits) used in the classification process, and the measurement data are multiplied 1.2 times to generate a second classification data of child blood by compressing the integer part of the multiplied data to 8-bit integer sequence information. The classification process is then executed on the generated second classification data. A proportion which maintains the continuity of the integer values can be increased thereby. That is, since the 12-bit integer sequence information is multiplied 1.2/16 times when generating the second classification data for child blood compared to multiplying the 12-bit integer sequence information 1/16 times when generating the first classification data for adult blood, the range of the measurement data which are the same integer values when multiplied 1.2/16 times is broadened, thus making errors difficult to occur.
For example, consider the case when the number of each element (X1, X2) (where X1, X2=0, 1, 2 . . . ) is designated F in two-dimensional distribution data DN which has N×N (N being a natural number) individual elements, and the two-dimensional distribution data Dn are compressed to two-dimensional distribution data Dm which has M×M (M being a natural number) individual elements. Furthermore, M<N obtains.
Each element (X1, X2) in the two-dimensional distribution data which has N×N individual elements corresponds to the elements (U1, U2) (where U1, U2=0, 1, 2, . . . ) shown in equation (1) in the distribution data Dm. In equation (1), Int(x) is a function which represents the integer part of the argument x. This is equivalent, for example, to the process of compressing 12-bit measurement data to 8-bits.
(U1,U2)=(Int(X1(M/N),Int(X2(M/N) (1)
Next, when the two-dimensional distribution data DL which has L(L individual elements in a partial region within the two-dimensional distribution data Dm are converted to two-dimensional distribution data which has M(M individual elements (L<M<N), the elements (X1, X2) (where X1, X2=0, 1, 2, . . . , N(L/M) in the distribution data Dn corresponds to the elements (V1, V2) (where V1, V2=0, 1, 2, . . . , M) in the distribution data Dm1, as shown in equation (2). This is equivalent to a process which shifts up the 8-bit data.
(V1,V2)=(Int(X1(M2/(N(L),Int(X2(M2/(N(L) (2)
That is, the number of elements of the distribution data Dm1 can be calculated and converted to smooth distribution data by initially converting (expanding) the two-dimensional distribution data DL which have an L(L element partial region to two-dimensional distribution data which have N(N elements, and then converting to two-dimensional distribution data which have M(M elements.
Returning to
Returning to
When the CPU 21 has determined to not execute reanalysis based on child blood (step S1201: NO), the CPU 21 reads the first classification data from the memory device 23 (step S1203). The CPU 21 executes the classification process based on the read first classification data or second classification data (step S1204), and counts the numbers of classified lymphocytes, monocytes, eosinophils, neutrophils, and basophils. The CPU 21 stores the count results in the memory device 23 (step S1206), displays the classification results on the display device 25 (step S1207), and the process returns to step S912.
Note that “Child” in this case may mean a newborn, infant, or toddler. The user of the biological sample analyzer of this embodiment may optionally set the sample analyzer, for example, so that a patient admitted to a pediatric department or obstetrics and gynecology department is designated as a “child,” or a child who is a preschooler may be designated as a “child,” rather than a patient less than a predetermined age. The manufacturer who fabricates the biological sample analyzer may also set the range of the “child.”
Returning to
The controller 91 of the measuring device 1 determines whether or not shutdown instruction information has been received (step S921); when the controller 91 has determined that shutdown instruction information has not been received (step S921: NO), the controller 91 returns the process to step S915 and the previously described process is repeated. When the controller 91 has determined that shutdown instruction information has been received (step S921: YES), the controller 91 executes shutdown (step S922) and the process ends.
According to the first embodiment described above, high precision analysis results can be obtained by changing the classification data of “child blood” and “adult blood”.
According to the first embodiment, it is possible to save time and a great deal of the expense required to develop various analysis programs because analysis processing can be executed using a shared common analysis program even when the ages of the patients differ.
Note that although a first classification data for adult blood and a second classification data for child blood are generated and stored in a memory device 23 before a user specifies re-analysis in the embodiment described above, the second classification data for child blood need not be generated until the user specifies re-analysis on the basis of child blood and then generating the second classification data at the time such specification has been made. In this case, the operation processing load on the device can be reduced since the second classification data are only generated when specified.
Although the classification process is executed for child blood when an instruction specifying the execution of a reclassification process for child blood has been issued by the user after the classification process for adult blood has been executed in the above embodiment, the present invention is not limited to this sequence. For example, the classification process for child blood may also be executed when it has been determined that the blood is child blood based on the age information stored in the patient information memory part 232.
Although the analysis process for adult blood and the analysis process for child blood are executed by respectively generating a first classification data for adult blood and second classification data for child blood then performing a classification process based on the first classification data and performing a classification process based on the second classification data, the present invention is not limited to this sequence. The first classification data for adult blood and the second classification data for child blood may also be identical, then the first classification data may be processed using an adult blood cell classification method in the case of adult blood, and the second classification data may be processed using a child blood classification method in the case of child blood. For example, when classifying white blood cells, the previously mentioned lymphocyte distribution region, the monocyte distribution region and the like (refer to
Although white blood cells are analyzed using the second classification data for child blood when a re-analysis instruction is issued from the user and the classification results are subsequently displayed in the first embodiment, the present invention is not limited to this arrangement. A classification process based on the first classification data for adult blood and a classification process based on the second classification data for child blood may both be executed before a re-analysis instruction is issued by the user. Furthermore, the classification results based on adult blood and the classification results based on child blood may be prestored in the memory device so that the classification results based on child blood can be displayed when an instruction to display the classification results based on child blood has been issued by the user.
The biological sample analyzer of a second embodiment of the present invention is described in detail below based on the drawings. Structures of the biological sample analyzer of the second embodiment of the present invention which are identical to the first embodiment are designated by like reference numbers and detailed description thereof is omitted. The second embodiment differs from the first embodiment in that the patient age information is obtained before starting the blood sample measurements, and whether or not the measurement sample is adult blood or child blood is determined based on the age information and thereafter the measurement data are obtained in accordance with the corresponding measurement condition.
The CPU 21 of the operation display device 2 determines whether or not a measurement start instruction has been received (step S1303); when the determination of the CPU 21 is that a measurement start instruction has not been received (step S1303: NO), the CPU 21 skips the subsequent steps S1304 through S1310. When the CPU 21 has determined that a measurement start instruction has been received (step S1303: YES), the CPU 21 transmits instruction information specifying to start a measurement to the measuring device 1 (step S1304). The controller 91 of the measuring device 1 determines whether or not instruction information specifying to start a measurement has been received (step S1314); when the controller 91 has determined that instruction information specifying to start a measurement has been received (step S1314: YES), the controller 91 has the barcode reader (not shown in the drawing) read the barcode label (not shown in the drawing) adhered to the container which contains the blood to obtain the blood identification information (sample ID) (step S1315). When the controller 91 has determined that instruction information specifying to start a measurement has not been received (step S1314:NO), the controller 91 skips steps S1315 through S1321.
The controller 91 transmits the obtained identification information (sample ID) to the operation display device 2 (step S1316), and the CPU 21 of the operation display device 2 determines whether or not the identification information (sample ID) has been received (step S1305). When the CPU 21 determines that the identification information (sample ID) has not been received (step S1305: NO), the CPU 21 enters a reception standby state. When the CPU 21 determines that the identification information (sample ID) has been received (step S1305: YES), the CPU 21 obtains the patient information which includes the patient age information by querying the patient information memory section 232 of the memory device 23 (step S1306).
The CPU 21 transmits the obtained patient information to the measuring device 1 (step S1307), and the controller 91 of the measuring device 1 determines whether or not the patient information has been received (step S1317). When the controller 91 determines that the patient information has not been received (step S1317: NO), the controller 91 enters the reception standby state. When the controller 91 determines that the patient information has been received (step S1317: YES), the controller 91 then determines whether or not the measurement object blood is child blood based on the received patient information (step S1318). Specifically, the measurement object blood is determined to be child blood if the patient age is a predetermined age, for example, an age of less than 1 year.
When the controller 91 determines that the measurement object blood is child blood (step S1318: YES), the controller 91 starts the measurement of the blood using the measurement condition for child blood (step S1319). Specifically, when performing the measurement for child blood, the controller 91 controls the sample preparing section 41 so as to prepare a measurement sample, and thereafter sets the operating voltage of the PD 512 and APD 511 of the detecting section 5 to 290 V, and detects the side scattered light and side fluorescent light from the blood cells in the measurement sample. Specifically, the electrical signals corresponding to the intensity of the received side scattered light and side fluorescent light are transmitted to the control board 9 via the detecting section 5 and the analog processing section 6. The A/D converter 92 of the control board 9 converts the obtained analog signals to 12-bit digital signals, and the operation section 93 performs predetermined processing to the digital signals output from the A/D converter 92, and transmits the signals to the controller 91.
On the other hand, when the controller 91 determines that the measurement object blood is not child blood (step S1318: NO), the controller 91 starts the measurement of the blood using the measurement condition for adult blood (step S1320). Specifically, the controller 91 controls the sample preparing section 41 so as to prepare a measurement sample, and thereafter sets the operating voltage of the PD 512 and APD 511 of the detecting section 5 to 280 V, and detects the side scattered light and side fluorescent light from the blood cells in the measurement sample. The subsequent measurement sequence is identical to that for child blood and is therefore not described in detail. Thus, the operating voltage is set at 290 V for the PD 512 and APD 511 of the detecting section 5 when measuring child blood compared to setting the operating voltage at 280 V for the PD 512 and APD 511 of the detecting section 5 when measuring adult blood, so that the same fluorescent intensity can be obtained when measuring child blood which contains blood cells which are difficult to stain as when measuring adult blood. Analysis results can therefore be obtained with excellent precision by the analysis process which is described below, even without performing the child blood analysis process.
Note that the amount of the staining solution used when preparing the measurement sample may be changed depending on whether adult blood measurement is performed or child blood measurement is performed. For example, 25 μl if staining solution may be used to prepare child blood measurement samples, whereas 20 μl of staining solution may be used to prepare adult blood measurement samples. Thus, fluorescent light of the same intensity as adult blood can be obtained from the blood cells contained in child blood.
When preparing a child blood measurement sample, the amount of hemolytic agent added to the blood may also be greater than when preparing an adult blood measurement sample And the hemolysis time may be increased to facilitate adequate hemolysis and staining of the blood cells contained in child blood by the staining solution. The staining time may also be increased to adequately stain the blood cells in child blood.
The illumination intensity of the light from the light source 501 may also be higher when measuring child blood than when measuring adult blood, and the electric signals subjected to photoelectric conversion by the PD 51 and APD 511 may be amplified by an increased amplification factor in the amplifiers 62 and 63.
The controller 91 transmits the received 12-bit integer sequence information as measurement data to the operation display device 2 (step S1321). The CPU 21 of the operation display device 2 determines whether or not measurement data have been received (step S1308); when the CPU 21 determines that measurement data have not been received (step S1308: NO), the CPU 21 enters the reception standby state. When the CPU 21 determines that the measurement data have been received (step S1308: YES), the CPU 21 executes the analysis process on the received measurement data (step S1309), and displays the analysis results on the display device 25 (step S1310).
The CPU 21 determines whether or not a shutdown instruction has been received (step S1311); when the CPU 21 determines that a shutdown instruction has not been received (step S1311: NO), the CPU 21 returns the process to step S1303 and the process described above is repeated. When the CPU 21 has determined that a shutdown instruction has been received (step S1311: YES), the CPU 21 transmits shutdown instruction information to the measuring device 1 (step S1312).
The controller 91 of the measuring device 1 determines whether or not shutdown instruction information has been received (step S1322); when the controller 91 has determined that shutdown instruction information has not been received (step S1322: NO), the controller 91 returns the process to step S1314 and the previously described process is repeated. When the controller 91 has determined that shutdown instruction information has been received (step S1322: YES), the controller 91 executes shutdown (step S1323) and the process ends.
Note that although the controller 91 of the measuring device 1 determines whether or not a sample is child blood based on the patient information received from the operation display device 2 in the second embodiment, the CPU 21 of the operation display device 2 may also determine whether or not a sample is child blood based on the patient information stored in the patient information memory part 232 and may transmit the determination result to the measuring device 1.
Whether or not a sample is child blood is not limited to being determined based on the age information stored in the patient information memory part 232 of the operation display device 2, inasmuch as the determination may also be made by a comprehensive determination which includes other information. Furthermore, a configuration may pre-provide a memory part for storing the age information in the measuring device 1, and the patient age information of a patient can be input by a user and stored in the memory part in the display and operation unit 7 so that the determination can be made based on the age information stored in the memory part.
A screen for setting a child blood mode which performs measurements of measurement object blood under condition used for child blood, or an adult blood mode which performs measurements under condition used for adult blood, may be displayed on the display device 25 of the operation display device 2 or on the display and operation section 7 of the measuring device 1, so that the measurement of the blood is performed in a user-set mode.
According to the second embodiment described above, characteristic information of blood cells in blood can be respectively obtained under measurement condition suited for adults when a patient is an adult and under measurement condition suited for children when the patient is a child by changing the measurement condition of the sample blood based on whether the patient is adult or child. Therefore, influences caused by differences in the degree of staining of the blood cells can be suppressed, and high precision analysis results can be obtained.
Note that although a blood analyzer which analyzes blood cells contained in blood which is used as a sample is described by way of example in the above first and second embodiments, the present invention is not limited to these examples inasmuch as the same effect may be expected when the present invention is applied to a biological sample analyzer which analyzes samples which contain biological particles such as cells in urine. Although the analysis results are displayed by the display device 25 of the operation display device 2 in the first and second embodiments described above, the present invention is not specifically limited to this example inasmuch as the results may also be displayed on a display device of another computer connected to a network.
Although the patient age information is associated with a sample ID in the patient information memory part 232 in the first and second embodiment described above, the present invention is not limited to this arrangement inasmuch as, for example, information which indicates a patient is newborn, infant, toddler or the like may also be prestored in the patient information memory section 232.
Although the first classification data and second classification data are generated by obtaining 12-bit integer sequence information as measurement data from the measuring device 1 and compressing the 12-bit integer sequence information to 8-bit integer sequence information in the first and second embodiments described above, the present invention is not limited to this configuration. For example, 16-bit integer sequence information may also be obtained from the measuring device 1 and used to generate 10-bit classification data. Moreover, the measurement data and classification data need not necessarily be integer sequence information.
In the first and second embodiments described above, the 12-bit integer sequence information obtained from the measuring device 1 is directly compressed to 8-bit integer sequence information when generating the first classification data for adult blood, and the 12-bit integer sequence information is multiplied by 1.2 and thereafter the integer sequence information is compressed to 8-bit integer sequence information when generating the second classification data for child blood; however, the present invention is not limited to this configuration. The 8-bit integer sequence information may be obtained as measurement data from the measuring device 1 and the 8-bit integer sequence information obtained from the measuring device 1 may be directly used when performing the classification process for blood cells in adult blood, and the 8-bit integer sequence information obtained from the measuring device 1 may be multiplied by 1.2 to obtain integer sequence information to be used when performing the classification process for blood cells in child blood.
In the embodiments described above, the conditions of the analysis process and the measurement process are determined based on whether a patient is adult or child; however, the present invention is not limited to this configuration. The conditions of the analysis process and the measurement process may also be determined based on whether a patient has a predetermined attribute. For example, the determination may be made based on whether a patient has a predetermined disease, or may be made based on whether a patient has been administered a predetermined medication. Such attribute information is desirably associated with the sample ID and prestored in the patient information memory part 232.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2008-088828 | Mar 2008 | JP | national |
